MJP Associates’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.71M | Sell |
3,481
-90
| -3% | -$70.1K | 0.4% | 29 |
|
|
2025
Q1 | $2.95M | Buy |
3,571
+74
| +2% | +$61.1K | 0.53% | 30 |
|
|
2024
Q4 | $2.7M | Buy |
3,497
+217
| +7% | +$168K | 0.49% | 31 |
|
|
2024
Q3 | $2.91M | Buy |
3,280
+276
| +9% | +$245K | 0.55% | 29 |
|
|
2024
Q2 | $2.72M | Buy |
3,004
+10
| +0.3% | +$9.05K | 0.57% | 27 |
|
|
2024
Q1 | $2.33M | Buy |
2,994
+604
| +25% | +$470K | 0.51% | 28 |
|
|
2023
Q4 | $1.39M | Sell |
2,390
-8
| -0.3% | -$4.66K | 0.37% | 28 |
|
|
2023
Q3 | $1.29M | Buy |
2,398
+183
| +8% | +$98.3K | 0.37% | 26 |
|
|
2023
Q2 | $1.04M | Buy |
2,215
+602
| +37% | +$282K | 0.34% | 35 |
|
|
2023
Q1 | $554K | Buy |
1,613
+41
| +3% | +$14.1K | 0.17% | 65 |
|
|
2022
Q4 | $575K | Buy |
1,572
+503
| +47% | +$184K | 0.17% | 61 |
|
|
2022
Q3 | $346K | Buy |
1,069
+45
| +4% | +$14.6K | 0.1% | 85 |
|
|
2022
Q2 | $332K | Buy |
1,024
+167
| +19% | +$54.1K | 0.09% | 89 |
|
|
2022
Q1 | $245K | Sell |
857
-147
| -15% | -$42K | 0.06% | 129 |
|
|
2021
Q4 | $273K | Buy |
1,004
+117
| +13% | +$31.8K | 0.08% | 117 |
|
|
2021
Q3 | $205K | Buy |
887
+17
| +2% | +$3.93K | 0.07% | 134 |
|
|
2021
Q2 | $200K | Buy |
+870
| New | +$200K | 0.07% | 134 |
|